Brookfield Corporation (BN), a leading alternative asset manager with over $1 trillion in assets under management, is set to report Q1 2026 earnings on May 14. From what I see, this release will be particularly important as it provides an update on the progress from 2025's record $6 billion in distributable earnings (DE), which rose 11% per share year-over-year. Investors like me are focused on the momentum in fee-related earnings (FRE), which grew 22% last year thanks to $112 billion in fundraising that pushed fee-bearing capital past $600 billion. Even with volatile markets and headwinds in real estate, BN's diversification across real estate, infrastructure, renewables, and credit highlights its resilience. The strong Q4 results, including a 17% dividend increase to $0.07 quarterly, lifted shares, but sustained execution on capital deployment and DE growth will be crucial for meeting those 15%+ annual targets.
Consensus estimates point to Q1 EPS of $0.65 and revenue of around $1.63 billion, based on forecasts from sources like MarketBeat and Yahoo Finance. This fits with BN's emphasis on distributable earnings before realizations (DEBR), which reached $1.5 billion ($0.63/share) in Q4 2025, up 11% per share from the prior year. I anticipate updates on FRE from the asset management segment, where BN holds 73% ownership in Brookfield Asset Management, and Q1 fundraising already hit $21 billion year-to-date. Wealth solutions and operating businesses performed well last year, with DE up 24% in insurance. BN has a track record of beating EPS estimates, as seen in Q4 2025 ($0.67 vs. $0.61 expected), which led to post-earnings gains. Key areas to watch include fee-bearing capital growth, realizations, and guidance for 15%+ DE expansion. The stock typically reacts with +5-10% moves on beats, showing its sensitivity to these growth indicators.
Heading into earnings, sentiment feels cautiously optimistic to me. BN shares are up modestly year-to-date in 2026 (~0.5%) but have trailed broader markets due to real estate sector pressures. Analysts hold a "Moderate Buy" rating with price targets suggesting 18-20% upside to $55+, based on expectations for durable growth. The positive ESP of +0.52% points to a likely beat, though risks like macroeconomic slowdowns could affect fundraising or realizations. Implied volatility indicates potential 5-7% moves post-earnings, with more upside likely on strong FRE and DE updates.
In reviewing BN, I also checked this using Tickeron’s AI Screener, which helps me filter stocks and ETFs based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. It scans thousands of names with customizable filters like industry, market cap, technical indicators, price patterns, and performance metrics, making it easier to spot trade ideas, breakout candidates, and opportunities compared to manual screening. This tool has become part of my routine for efficiently comparing BN to peers in the asset management space.
BN is targeting 15%+ annual DE per share growth, supported by scaling asset management to over $1 trillion in AUM. After Q1, I'll be watching updates on fee-bearing capital—last reported at $603 billion—and fundraising momentum, which has already reached $67 billion year-to-date through affiliates like BAM.
Wealth solutions, with insurance assets exceeding $120 billion, delivered 24% DE growth in 2025; I'll monitor inflows and investment yields there. Operating businesses are navigating real estate cycles but gain from inflation-linked contracts in infrastructure and renewables.
Guidance from the earnings call should shed light on the 2026 path, especially with M&A activity like potential Oaktree integration and capital recycling. Cost discipline and strong liquidity ($41 billion corporate) back the recent 17% dividend hike.
One thing that stands out is how industry dynamics, such as AI-driven demand for data centers, could lift infrastructure and renewables. Keep an eye on margin pressures from interest rates and demand in credit and private equity. In my view, BN's balanced approach sets it up for compounded returns over time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
BN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on May 12, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on June 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BN as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where BN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
BN moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BN advanced for three days, in of 352 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 283 cases where BN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.333) is normal, around the industry mean (3.934). BN has a moderately high P/E Ratio (87.451) as compared to the industry average of (25.672). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.708). BN has a moderately low Dividend Yield (0.006) as compared to the industry average of (0.092). P/S Ratio (1.393) is also within normal values, averaging (17.397).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an alternative asset manager which owns, manages and operates real estate, financial and power generation related businesses
Industry InvestmentManagers